These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30458722)

  • 61. Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations.
    Imberti JF; Vitolo M; Proietti M; Diemberger I; Ziacchi M; Biffi M; Boriani G
    Expert Rev Med Devices; 2020 Apr; 17(4):297-308. PubMed ID: 32160800
    [No Abstract]   [Full Text] [Related]  

  • 62. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
    Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
    Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator.
    Curtis AB; Conti JB; Tucker KJ; Kubilis PS; Reilly RE; Woodard DA
    J Am Coll Cardiol; 1995 Jul; 26(1):180-4. PubMed ID: 7797749
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V; Perault R; Bories MC; Narayanan K; Garcia R; Combes N; Perier MC; Defaye P; Sadoul N; Gras D; Klug D; Bordachar P; Fauchier L; Deharo JC; Leclercq C; Boveda S; Marijon E; Babuty D;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):758-765. PubMed ID: 30078651
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Resumption of driving after life-threatening ventricular tachyarrhythmia.
    Akiyama T; Powell JL; Mitchell LB; Ehlert FA; Baessler C;
    N Engl J Med; 2001 Aug; 345(6):391-7. PubMed ID: 11496849
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Significant regional variation in use of implantable cardioverter-defibrillators in Denmark.
    Pedersen SB; Farkas DK; Hjortshøj SP; Bøtker HE; Johansen JB; Philbert BT; Haarbo J; Thomsen RW; Nielsen JC
    Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):352-360. PubMed ID: 30785188
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation.
    Januszkiewicz Ł; Barra S; Marijon E; Providencia R; de Asmundis C; Chun JKR; Farkowski MM; Conte G; Boveda S
    Europace; 2023 Mar; 25(3):1144-1151. PubMed ID: 36691111
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.
    El-Chami MF; Levy M; Kelli HM; Casey M; Hoskins MH; Goyal A; Langberg JJ; Patel A; Delurgio D; Lloyd MS; Leon AR; Merchant FM
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):900-904. PubMed ID: 25952566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.
    Kim M; Kim J; Lee JH; Hwang YM; Kim MS; Nam GB; Choi KJ; Kim JJ; Kim YH
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1191-1198. PubMed ID: 27334231
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monitoring treatment expectations in patients with an implantable cardioverter-defibrillator using the EXPECT-ICD scale.
    Habibović M; Pedersen SS; van den Broek KC; Denollet J
    Europace; 2014 Jul; 16(7):1022-7. PubMed ID: 24596397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators.
    Hreybe H; Saba S
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):385-9. PubMed ID: 17367358
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience.
    Curnis A; Mascioli G; Bontempi L; Cerini M; Bignotti T; Bonetti G; Dei Cas L
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1241-5. PubMed ID: 19001931
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.
    Irfan G; Czapla J; Saitoh Y; Ciconte G; Mugnai G; Conte G; Hunuk B; Velagic V; Stroker E; Chierchia GB; Nijs J; La Meir M; Wellens F; Brugada P; De Asmundis C
    Europace; 2017 Jan; 19(1):81-87. PubMed ID: 26893495
    [TBL] [Abstract][Full Text] [Related]  

  • 78. COPE-ICD: a randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population.
    Berg SK; Svendsen JH; Zwisler AD; Pedersen BD; Preisler P; Siersbæk-Hansen L; Hansen MB; Nielsen RH; Pedersen PU
    BMC Cardiovasc Disord; 2011 Jun; 11():33. PubMed ID: 21682864
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Philbert BT; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Sep; 20(FI2):f217-f224. PubMed ID: 29684191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.